Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Dec 13, 2022
Trial Information
Current as of January 13, 2025
Completed
Keywords
ClinConnect Summary
Social isolation is common in serious mental illness and has a profound negative impact on recovery. This study evaluates a new technology-supported blended intervention, mobile Social Interaction Therapy by Exposure (mSITE), that targets social behavior, and it also validates several new techniques for measuring social behavior. mSITE blends brief in-person psychotherapy with context-triggered mobile smartphone intervention and remote telephone coaching. The investigators will conduct an open trial of mSITE, evaluating whether the intervention leads to clinically significant changes in the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Voluntary informed consent to participate and capacity to consent;
- • 2. Age 18 to 65;
- • 3. DSM-5 diagnosis of schizophrenia, schizoaffective, bipolar I disorder or major depression with history of psychosis based on a SCID-5 interview and available medical record review;
- • 4. Minimum level of social avoidance defined by a score of ≥ 2 on the Scale for the Assessment of Negative Symptoms (SANS) asociality item;
- • 5. ≥ 6th grade reading level on the Wide Range Achievement Test-4 Reading subtest (to read therapy workbook).
- Exclusion Criteria:
- • 1. Prior CBT in the past 2 years;
- • 2. Greater than moderate disorganization on the PANSS (P2- Disorganization item \>5);
- • 3. DSM-5 alcohol or substance dependence in past 3 months based on the SCID;
- • 4. Level of care required interferes with outpatient therapy (e.g., hospitalized; severe medical illness)
- • 5. Unable to adequately see or manually manipulate a phone;
- • 6. Resident of an integrated housing facility that also provides treatment services.
Trial Officials
Eric Granholm, PhD
Principal Investigator
University of California, San Diego; San Diego Veterans Healthcare System
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials